(Q52891216)

English

Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?

scientific article published on 7 December 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease? (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

1 reference

based on heuristic

inferred from title

Alexander Visekruna

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

Stefan Kaufmann

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

Ulrich Steinhoff

object named as

U Steinhoff

6

0 references

author name string

M Lawrenz

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

A Kühl

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

N Schmidt

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

publication date

7 December 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

Mucosal Immunology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

129-139

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

https://scigraph.springernature.com/pub.10.1038/mi.2011.57

0 references

The immunological and genetic basis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

The genetics and immunopathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 beta production.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Chemically induced mouse models of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

The role of chemokines in intestinal inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNF in LPS-stimulated macrophages

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Innate immune mechanisms of colitis and colitis-associated colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Common variants in the NLRP3 region contribute to Crohn's disease susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

The Nlrp3 inflammasome: contributions to intestinal homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

NF-kappaB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Constitutive intestinal NF-κB does not trigger destructive inflammation unless accompanied by MAPK activation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Targeting protein kinases for the development of anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Pharmacologic inhibition of tpl2 blocks inflammatory responses in primary human monocytes, synoviocytes, and blood.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

21 January 2018

Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of thieno[2,3-c]pyridines as potent COT inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.57

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MI.2011.57

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/22157885

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52891216&oldid=1456872717"